Hexagon Capital Partners LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hexagon Capital Partners LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$6,288
+36.4%
76
+40.7%
0.00%0.0%
Q1 2024$4,609
+1243.7%
54
+1250.0%
0.00%
Q4 2023$343
-94.8%
4
-94.5%
0.00%
-100.0%
Q3 2023$6,539
-56.6%
73
-58.8%
0.00%
-50.0%
Q2 2023$15,070
+48.1%
177
+43.9%
0.00%
+33.3%
Q1 2023$10,178
-15.4%
123
-19.6%
0.00%0.0%
Q4 2022$12,033
+20.3%
153
+11.7%
0.00%0.0%
Q3 2022$10,0001370.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders